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Context 
Internationally, hospital readmissions have a great appeal as an indicator of hospital quality. 
Since possibilities in prevention and control exist, reducing rates of hospital readmission has 
attracted attention of policymakers as a way to improve quality of care while simultaneously 
reducing costs. Therefore reducing the number of readmissions is considered to be a pillar of 
more cost-effective hospital care. The goal of this study was to estimate the cost of hospital 
readmissions at a national level, describe differences in readmission rates between hospitals 
and to calculate the potential monetary savings of reducing excess readmissions. 
 
Methods 
Stays data were obtained from the Minimum Basic Data Set 2008 in a sample of 45 Belgian 
hospitals representing 16,141 beds. Readmissions were identified as a second admission for 
the same patient with the same APR-DRG code within respectively 1 month or 3 months after 
discharge. Hospital type, diagnosis-related group, age and gender were used as matching 
factors in comparing readmission rates. Readmissions that occur naturally in each other's 
proximity due to the repeating nature of therapy were excluded. The costs per readmission 
were then calculated by linking the stays data with the cost data per APR-DRG and per 
severity index using the 2008 national feedback. The results of our sample were then 
extrapolated to all Belgian hospitals. We performed a sensitivity analysis to estimated 
potential monetary savings when a reduction in the incidence of readmissions in hospitals 
having a higher readmission rate in comparison to other hospitals is realized.  
 
Results 
In our sample 1.5% readmissions (N= 19,454) within 1 month after discharge and 2.1% 
(N=27,051) within 3 months after discharge were identified. The Readmission rate within one 
month varied between 0.82% and 5.55% (Md= 1.38%, SD= 0.74%), after three months the 
readmission rate varied from 1.17% up to 6.40% (Md= 1.97%, SD= 0.80%).  
The additional weighted mean cost of these readmissions was € 3,495.58 within 1 month and 
€ 3,572.20 within 3 months. The total financial burden, as extrapolated to the Belgian setting, 
is estimated at € 280,091,471 (3 months). 
We provide a full overview of the potential monetary savings when reductions in readmission 
rates are realized by applying different thresholds. For instance, if all Belgian hospitals having 
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a higher readmission rate improve their rate to the level of the hospital corresponding to 
percentile 75 (or 65) savings would amount to € 14,118,509 (or € 18.752.623). 
 
Discussion 
By reducing readmission rates, quality of care can be increased while at the same time lowering 
delivery costs. This theme is an international leading topic of practice and policy reform. 
Unplanned, early or preventable readmissions can be seen as a system failure. There is a growing body 
of evidence that targeted interventions initiated before and shortly after discharge can decrease the 
likelihood of readmissions. As such, these interventions are an opportunity to improve quality of 
hospital care while simultaneously reducing the cost of care delivery. The shortening of Length of 
Stay has been frequently regarded as discharging patients ‘quicker but sicker’, stressing the 
importance of follow-up after discharge. The current fragmentary financing system divides the 
trajectory of patients in different virtual stages and throughout a single course of treatment separate 
payments are made to providers. This contrasts the idea of ‘care programs’ and the expected integrated 
care delivery by patients. 
 
